November 8 to December 2, 2005, call toll-free to join your colleagues for a stimulating, live exchange of ideas on the challenge of managing post-MI heart failure.

Program Description
Each 1-hour interactive teleconference includes a short introduction, a 20- to 25-minute presentation, and a 10- to 15-minute question-and-answer session with a member of the faculty. Participants are encouraged to ask questions to ensure a lively discussion.
This Web site contains faculty names and biographies and the teleconference schedule from November 8 to December 2, 2005. To register, please follow the instructions found on the registration tab. Five days prior to your scheduled teleconference you will receive a continuing education workbook containing information regarding your participation in the program.

To Register
Review the Teleconference Schedule to select a date and time convenient for you. Click on Registration to fill out the registration form online.

Target Audience Cardiologists, nurses, pharmacists

Goal To provide practitioners with current data and expert commentary on aldosterone blockade in the management of post-MI heart failure.

Learning Objectives
Upon completion of this activity, participants should be better able to:
• Describe the role of aldosterone in the pathophysiology of heart failure.
• State the results of recent trials involving aldosterone blockers.
• Use aldosterone blockers safely and effectively in patients with post-MI heart failure, particularly with regard to risk factors for hyperkalemia.

Faculty
Gregg C. Fonarow, MD
Barry H. Greenberg, MD
Bertram Pitt, MD

How to Receive Credit
To qualify for continuing education contact hours or credits, you must participate for the entire teleconference and submit the evaluation form. The estimated time to complete the entire activity is about 1 hour.

After participation in the program, pharmacists may obtain credit online by clicking here.

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of New York Medical College (NYMC) and the Continuing Education Alliance. NYMC is accredited by the ACCME to provide continuing medical education for physicians. NYMC designates this educational activity for a maximum of 1 category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those credit(s) that he/she actually spent in the activity.

This activity for 1.0 contact hours is provided by the University of Nebraska Medical Center, College of Nursing Continuing Nursing Education, which is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation. Iowa Provider #78. Additionally, provider approved by the California Board of Registered Nursing, Provider #13699 for 1.0 contact hours.

The Continuing Education Alliance is accredited by the Accreditation Council on Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1 contact hour (0.1 CEU). Universal Program Number 270-999-05-004-L01.

The providers of this program have waived the processing fees.

We gratefully acknowledge Pfizer Inc for its generous support of this educational activity.